Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares Repurchased
Ratios

Definitive Healthcare (DH) EBIAT (2020 - 2026)

Definitive Healthcare filings provide 6 years of EBIAT readings, the most recent being $43.2 million for Q4 2025.

  • On a quarterly basis, EBIAT rose 151.01% to $43.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$138.9 million, a 74.01% increase, with the full-year FY2025 number at -$138.9 million, up 76.51% from a year prior.
  • EBIAT hit $43.2 million in Q4 2025 for Definitive Healthcare, up from -$17.8 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $73.9 million in Q4 2023 to a low of -$306.2 million in Q2 2024.
  • Median EBIAT over the past 5 years was -$12.2 million (2023), compared with a mean of -$47.0 million.
  • The widest YoY moves for EBIAT: up 648.88% in 2023, down 3512.03% in 2023.
  • Definitive Healthcare's EBIAT stood at -$9.9 million in 2021, then skyrocketed by 200.03% to $9.9 million in 2022, then soared by 648.88% to $73.9 million in 2023, then tumbled by 214.67% to -$84.7 million in 2024, then skyrocketed by 151.01% to $43.2 million in 2025.
  • The last three reported values for EBIAT were $43.2 million (Q4 2025), -$17.8 million (Q3 2025), and -$9.3 million (Q2 2025) per Business Quant data.